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Summary 
More often known as the “morning after” pill, the Emergency Contraceptive Pill (ECP) has been used for 
over 30 years throughout the world as a method for preventing unwanted pregnancy. EC is a unique 
contraceptive preventing unwanted pregnancy after unprotected or poorly protected sexual intercourse.
Access to EC is an important part of  overall family planning (FP) strategies, especially in contexts 
where the magnitude of  unwanted pregnancies, violence, sexual abuse, and their consequences (unsafe 
abortions, infanticide) is high. The issue calls for greater attention by national stakeholders.
In Senegal, initiatives for mainstreaming EC in the FP program are fairly recent. EC was included in 
Senegal’s FP program in the mid 2000s, and by 2007-2008 it was included in the FP program’s policies 
and guidelines. Service statistics indicate, however, that ECP distribution through the public sector is 
very low (<2%). While most users access ECPs through the private sector, the volume of  sales is not 
clear, due to the absence of  an operational information system of  EC distribution through pharmacies.
In an effort to strengthen EC provision in Senegal and reposition EC within the FP program, Population 
Council conducted a study in collaboration with the Reproductive Health Division (RHD) of  the Ministry 
of  Health, Senegal to document the positions and perceptions of  Key Opinion Leaders (KOLs) who 
can shape the policy and program framework ; as well as documenting providers’ attitudes, beliefs, 
and practices regarding EC. Support for this study was provided by the International Consortium for 
Emergency Contraception, as part of  a three-country project also including Nigeria and India.
Study Objectives
Global objective
The study’s overall objective is collecting information from KOLs and providers about their EC 
knowledge, attitudes, and practices, and understanding their options and perceptions that may influence 
EC policies and programs.
Specific objectives
• Documenting providers’ EC attitudes, beliefs, and practices, including the issue of  repeat use ;
• Capturing KOL’s views and perceptions about EC policy and program issues ;
• Collecting suggestions and recommendations for establishing appropriate interventions for 
repositioning EC in public and private health sectors.
Methodology
Study sites
The study was conducted in August and September 2011 in Dakar and Thiès urban areas targeted by the 
“Urban Reproductive Health Initiative in Senegal” (ISSU) project, funded by the Bill and Melinda Gates 
Foundation.
Respondents
The study collected information from two types of  respondents: KOLs and EC providers, with 34 
KOLs and 155 providers interviewed. Targeted KOLs included public authorities, parliament members, 
professional association members, development partners, NGO representatives, religious leaders, 
pharmaceutical distributors, leaders of  community-based organizations, and private practitioners. 
Providers included a wide range of  cadres and included those currently providing, or have provided, EC, 
both in the public and private sectors, including doctors, midwives, nurses/ nurse assistants, pharmacists, 
and pharmacy counter staff, working in a number of  settings: public facilities, private clinics, NGO 




A considerable proportion of  providers (38%) have not received any EC training. Among those trained, 
about half  were trained as part of  on-the-job training. Nearly a third of  providers were never trained 
in FP counseling, and nearly four out of  10 providers have never received specific training on EC 
provision. Staff  in private pharmacies, especially counter staff, tends to be less trained. 
Providers have some ECP knowledge, but it can be strengthened. For example, improvements in 
knowledge about ECP’s mode of  action, its timing of  use, and eligibility criteria can be strengthened. 
Although many providers think ECP is a safe product, negative views persist. 
• While 72 percent of  providers indicate ECPs can be provided to all women, irrespective of  age 
or marital status, when questioned in-depth, responses are lower. Less than half  of  providers 
(43%) responded that all married women could receive ECPs, and the proportion drops for 
youth and adolescent girls (37%) ; 
• Forty-one percent of  trained providers were comfortable with ECPs sold without prescription, 
while the majority preferred tighter controls ;
• Most providers preferred EC provision limited to conventional health facilities such as hospitals, 
health centers, private clinics, and pharmacies: They do not favor extending EC at community 
and school levels through other supply means ;
• Opinions are mixed on EC use by married women, unmarried adolescents, and sex workers.
Analysis of  providers’ ECP perceptions indicates:
• Providers believe primary users of  EC are aged 15 to 29 years, particularly between 20 and 29 ;
• Providers do not favor regular EC use ;
• Providers feel EC users, more than others, are at greater risk of  acquiring STIs, have multiple 
sexual partners, and not use regular contraception ; 
• Over two-thirds of  providers indicated providing instructions on ECP use, and nearly two-
fifths reported answering client questions, but fewer providers referred clients to regular FP 
services (28%) or provided information that ECPs do not protect against HIV and STIs ;
• Norlevo® is the commonly prescribed ECP.
Key opinion leader survey 
Product beliefs:
• Apart from KOLs directly involved in the managing the reproductive health program, others, 
such as parliamentarians and other community leaders, are not as knowledgeable about EC. 
Different brands of  EC products are not known to KOLs, who stressed the need for informing 
communities about this product.
• Few KOLs are informed about ECP’s mode of  action ;
• Many KOLs indicated that EC is legal, available in the national program, and sold in private 
pharmacies ;
• Some KOLs cited low availability of  EC products, particularly in public health facilities, which 
have experienced stock shortages since 2010 due to the expiration of  the public sector ECP 
product, Pregnon® ;
• The vast majority of  KOLs have also raised EC’s high cost in private pharmacies, which remain 
first sources of  supply for EC users ;
• Legislation should be revised similarly to other contraceptive products: EC products are among 
Table A products, therefore requiring a prescription from a doctor or a midwife ;
• Although KOLs do not have specific information on EC guidelines and protocols, most are in 
favor of  integrating EC in the national guidelines for FP service provision ; 
• Few KOLs are aware of  EC studies in Senegal and their findings.
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Attitudes, opinions and perceptions relating to EC use:
• Most KOLs think ECPs are useful, especially among young people, because they help prevent 
unwanted pregnancies after unprotected sex, also in cases of  rapes and incest, as they can avoid 
health and social consequences such as induced abortion and infanticide ;
• KOLs indicated perceived reluctance among providers about offering EC services. A public 
official stated, “Among providers, there are still some stereotypes. They have not quite accepted this method. 
They are concerned about potential overuse. Providers are directing users towards other methods such as injections 
and implants ;”
• KOLs do not share uniform views of  preferred users of  EC. For some KOLs, “EC should be 
limited to certain women: those with high-risk pregnancies, women victims of  rape and sexual assault, sex 
workers and women having casual sex (e.g. migrants’ wives, teenagers)”. Others indicated “EC should be 
available to all women who need it and as long as there is no medical contra-indication for the method ;”
• KOLs urged caution in expanding EC access to the community level. A Ministry of  Health 
official said, “For extension to the health posts, there are no problems. But for health huts (i.e. facilities lower 
than health posts), I suggest we wait for the results of  the initial experience to be well established, because even 
health workers at this level may overuse it ;”
• KOLs believe repeat use of  EC is a reality, seen especially in pharmacies. They also believe, 
however, that repeat use can also increase risk of  STI exposure and substitute for regular 
contraception.
Recommendations
This study’s primary recommendations include:
• Informing communities for wider product knowledge ;
• Training providers ;
• Establishing a logistics management system ensuring product availability ;
• Improving product affordability ;
• Developing effective partnerships, especially with pharmacists ; 
• Increasing advocacy with decision makers.
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Introduction 
More commonly known as the “morning after pill,” the Emergency Contraceptive Pill (EC) has been 
used for over 30 years throughout the world as a method for preventing unwanted pregnancy. EC is a 
unique contraceptive that prevents unwanted pregnancy after unprotected or poorly protected sexual 
intercourse. It is the only contraceptive method available that can be used immediately after unprotected 
sexual intercourse has occurred. Because it is very different from a scope of  contraceptive methods, and 
because it efficiently prevents pregnancies for those families that use it, access to EC is an important 
part of  overall family planning (FP) strategies, especially in contexts where the magnitude of  unwanted 
pregnancies, violence, sexual abuse, and their consequences (e.g. unsafe abortions and infanticide) is 
high. The issue demands not only the attention but also the responsibility of  public authorities and 
stakeholders. 
Unfortunately, there is widespread ignorance in regards to this product, especially about its mechanism 
of  action and the effect EC has on procreation. High priority must be given, on the level of  reproductive 
health programs in general and of  Family Planning (FP) programs in particular, to the diffusion of  
accurate information on EC. 
In Senegal, initiatives for promoting EC are recent. The first initiative was sponsored by Equilibres et 
Population1, a partner of  the ECafrique network2, through a pilot introduction of  EC in ASBEF facilities 
from 2003-2005. Financed by the Compton Foundation3, this project was conducted in partnership 
with HRA PHARMA4. The goal was to introduce EC as a way to prevent unwanted pregnancies and 
unsafe abortions, and especially as a way to gear women towards regular contraceptive use. Activities 
focused on advocacy, the IEC, training providers, and the provision of  EC services. This pilot project 
demonstrated that the usefulness of  EC was well received by the public and that providers, once trained, 
found the product easy to administer. In 2005, ECafrique, in collaboration with Equilibres et Population, 
launched a sub-regional initiative on EC to strengthen lessons learned from the pilot intervention. This 
sub-regional initiative has engaged the Senegalese Ministry of  Health and Prevention in implementing 
training activities and IEC advocacy in favor of  EC. With support from Population Council, several 
studies have been conducted. The first study, “EC: A Glance at the Issue in Senegal” (2005), demonstrated 
the lack of  public knowledge about EC. The second study, done in 2006, was diagnostic. It showed the 
need to reinforce information on EC to providers and the community. In 2006, the strategic evaluation 
of  the national FP program revealed that providers as well as clients had limited knowledge of  EC. This 
assessment also showed that the provision of  EC services was limited to a few health centers and that 
the large majority of  providers had no specific EC training. These conclusions were corroborated by the 
Study of  Situational Analysis (AS) of  the reproductive health services that was conducted in 2007, which 
showed that only 10% of  Service Delivery Points (SDP) had dedicated EC products and that 37% of  
providers interviewed were not trained in EC. 
In 2008, in collaboration with the CEFOREP, a study on unwanted pregnancy prevention in schools in 
the area of  Pikine-Guédiawaye identified providers’ training, youth awareness, and improvement of  the 
availability and access to EC products as key actions to be undertaken in the context of  EC promotion. 
The conclusions of  these studies contributed to the integration of  EC in policies and reproductive 
health service norms. Already in 1998, EC was introduced into the curriculum for provider training. In 
2000, EC was mentioned for the first time in the Policies, Norms, and Protocols (PNP). These PNP 
mentioned that Combined Oral Contraceptives, progestin pills, and IUDs could be used as part of  EC. 
In 2005, Pregnon was introduced as the first dedicated EC method in the PNP. 
Between 2006-2010, through Population Council’s support, the Ministry of  Health was able to train 
almost 1,200 providers, pharmacists and pharmacists’ assistants, and health agents on EC provision and 
on how to educate clients about the use of  this product. Teaching materials were developed and distributed 
to providers and health workers in several regions. With the support of  UNFPA, the introduction of  
Pregnon in public sector SDPs enhanced accessibility to EC in the national health system. In the private 
sector, PRODIPHARMA has provided the distribution of  Norlevo since 2005. 
1 Equilibres et Population is an NGO based in Paris that was founded in 1993 by doctors and journalists to promote the proper use of  public aid for development.
2 The African Forum on Emergency Contraception or ECafrique is a network of  professionals involved in the field of  health that aims to increase the availability of  quality EC services in 
Africa. This network was created in 2002 and is sponsored by Population Council, an American NGO based in New York.
3 The Compton Foundation is a nonprofit organization based in California, USA, which aims to ensure human and environmental security and preserves the rights of  future generations.
4 HRA PHARMA is an institution whose objective is to develop and commercialize medicine or medical devices that meet real needs in health without raising the interests of  pharmaceuti-
cal companies. It developed Norlevo, which is an EC product.
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In 2009, the study conducted in private pharmacies revealed that they were still the main source of  EC 
provision and highlighted the need to harmonize EC provision procedure in the private sector. This 
study also showed the need to keep pharmacists and their assistants up to date on new EC provision 
protocols. 
In 2010, the Reproductive Health Division, with support from Population Council, performed an 
assessment of  the EC integration process into the national health system through a national forum on 
EC. This forum revealed that there was a real promotional problem regarding EC in the national health 
system despite the efforts made. 
Indeed, the following was noted: 
• A widespread lack of  public awareness about the product;
• Persistent rumors about EC due to the specificity and sensitive nature of  the product;
• Low inclusion of  EC in routine service delivery, especially during initial counseling and FP/
IEC awareness campaigns;
• Although private pharmacies are the main supply source for EC users, service providers at 
pharmacies need to be updated as to new EC provision protocols.
EC use in the public system remains very low if  one refers to routine statistics (<2%). In the private 
sector, because of  the lack of  a functioning information system, the actual use of  EC in pharmacies is 
not known. 
EC service delivery in the public sector continues to be hampered by insufficient promotion of  the 
product. The beliefs, attitudes, and practices of  the general population, and of  providers in particular, 
will impede the promotion and use of  this product with the groups who need it the most. 
Thus, in the context of  repositioning EC in FP programs, Population Council has conducted a study 
of  the attitudes, beliefs, and practices of  Key Opinion Leaders (KOLs) and providers around EC in 
collaboration with the Division of  Reproductive Health (DRH).
This study is part of  a multi-country study that also includes Nigeria and India. These three countries 
receive funding from the Bill & Melinda Gates Foundation in support of  the implementation of  Urban 
Health Initiative underway in these countries.
Goal of  the Study 




The study’s overall objective is to collect information from opinion leaders and providers about their EC 
knowledge, attitudes, and practices and to understand the options and perceptions that may influence 
EC policy and programs. 
Specific objectives
• To document providers’ EC attitudes, beliefs and practices, including the issue of  repeated use;
• To capture KOLs’ views and perceptions about EC policy and program issues;
• To collect suggestions and recommendations for establishing appropriate interventions for the 
repositioning of  EC in public and private health sectors.
Methodology
Study sites
• The study was conducted in August and September 2011 in urban areas in Dakar and Thiès 
targeted by the “Urban Reproductive Health Initiative in Senegal” (ISSU) project, funded by 
the Bill & Melinda Gates Foundation. The choice of  sites provides a good opportunity to 
collaborate with ISSU. 
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The choice of  the cities of  Dakar, Thiès, and Mbour is justified by: 
• Dakar: the choice of  Dakar is justified because it is the largest population center in the country 
and because it represents many of  the social and economic problems of  the country in general.
• Thiès: Thiès was chosen because it is the second urban center at the national level and because 
it is important to have an EC supply available outside of  Dakar. Thiès also houses a regional 
hospital and several private clinics. 
• Mbour: Mbour was included as an emerging urban center with an economic and social profile 
that differs from the two other choices. Mbour is characterized by its touristic profile, which 
exposes adolescents and youth to crucial problems linked to premature sexuality and its 
consequences (e.g. unwanted pregnancies).
Study target
The study targeted two types of  respondents: 
• Key Opinion Leaders (KOL) : this target includes public authorities (officials from the Ministries 
of  Health, National Education, Youth, and Gender, etc.), members of  parliament, members 
of  professional associations (Order of  Pharmacists, Order of  Doctors, midwives and 
women lawyers associations), representatives of  development partners, local NGO members, 
professional and religious networks (Journalists and Islamic networks, Siggil Jiggen network), 
pharmaceutical distributors, and members of  community-based organizations (CBO), especially 
women’s, youth, and private sector practitioner associations. The choice of  KOLs is justified by 
the fact that they play a major role in defining national policies and strategies and in resource 
allotment; the population listens to them and they can influence opinions. Their decisions 
matter so it is important to understand better their opinions and suggestions in order to build 
solid advocacy for EC repositioning. 
• Service providers: the provider survey targeted a wide range of  providers involved in FP service 
provision in the public, private, and semi-public sectors. These include doctors, midwives, 
nurses/nurses assistants, pharmacists and counter staff, providers involved in adolescent 
counseling centers, private clinics and NGO clinics, and school infirmaries.
Selection of sample population
Key opinion leaders: the selection of  KOLs was made after systematic decision-making; KOLs were chosen 
based on the interest and involvement of  their institutions with regards to EC and on the role and 
influence that these institutions could have on EC repositioning. 
Providers: at the first level, the selection was made based on Service Delivery Points (SDP) that usually 
provide FP services, including EC. The choice of  SDPs took into account the representation of  types 
of  SDPs (public/private/semi-public) and the level of  attendance of  the SDP by the population. These 
SDPs included public sector facilities (hospitals, health centers, and health posts), semi-public facilities 
(COUD Social Center, Dakar Dem Dikk, Social Security Office), private clinics and pharmacies, NGO 
clinics (ASBEF, ACDEV), and adolescent counseling centers. At the second level, providers who have, 
in the past, offered an EC method and those who continue to do so were included in the study and 
interviewed after having giving their consent. At least one provider per SDP was interviewed.
Data collection tools and issues explored
Key opinion leaders: a semi-structured interview guide was administered to each KOL. The issues explored 
focused on product knowledge (its legal status, its mechanism of  action, its efficacy, and its timing of  
use); EC service delivery; EC policies, norms, and protocols; EC research; EC perceptions, attitudes, and 
practices; barriers linked to delivery and access; EC use; and suggestions for EC promotion. Interviews 
were conducted by the study coordinator with support from a sociologist. 
Providers: an individual quantitative questionnaire was administered to providers. As with interviews with 
the KOLs, questions focused on product knowledge; EC perceptions, attitudes, and practices; EC use; 
and their experience with EC provision. Interviews were conducted by DHR coordinators who were 
previously trained in questionnaire administration.
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Ethical considerations
For both KOLs and service providers, an informed consent form was given before the beginning of  
the interview. Participation in the survey was voluntary and no compensation was given to participants. 
Interviews respected the privacy and the anonymity of  the interviewees throughout the survey and data 
processing through the use of  codes for all personal information related to participants. No name was 
recorded. 
Data management and analysis
The provider survey: data entry was done with Epidata software; the data was transferred to SPSS for 
analysis. Univariant and bivariant analyses were performed. 
The KOL survey: content analysis was used for qualitative information processing gathered from the 
KOLs. This analysis was done along similar themes to allow for comparison between the three countries 
covered by the study. 
Assessment of  Data Collection 
Key Opinion Leaders (KOL)
Table 1 shows KOL distribution by profile. A total of  34 KOLs were interviewed, of  which 11 are 
involved in public institutions (officials from the Ministries of  Health, Education, Justice, Youth, 
members of  parliament, etc.), five are members of  professional and religious associations (Women 
lawyers and Islamic associations, etc.), four are representatives of  development partners, and the rest are 
representatives of  institutions involved in EC distribution (National Supply Pharmacy, head of  logistics 
at the DRH, PRODIPHARM), members of  Community based organizations (CBO) (such as Synergie 
Banlieue and Youth Action Movement), and private practitioners. The wide choice of  different targeted 
institutions in this study responded to the need for a diversified picture of  officials’ opinions (public 
policy, civil society, community and NGO decision makers). These officials are likely play a role in 
determining policy and program choices for EC repositioning.
Table 1: Distribution of  KOL by profile
KOL profile Number
Policy and program decision makers 11





Community based organization members 7
Total 34
Source: : KOL survey, July 2011
Providers 
The provider survey covered a wide range of  SDPs including public, private, and semi-public health 
sanitary facilities. 109 SDPs were visited, of  which 36 were pharmacies, 26 were health posts, 13 were 
private clinics, and 15 were health centers. The sampling also included specific facilities such as counseling 
centers for adolescents (4) and school infirmaries, which are specifically designed for adolescents/youth 
in school settings (2). Most of  the SDPs are concentrated in Dakar (82% of  SDPs).
Table 2: Distribution of  Service Delivery Points by type 
Type of  facilities visited Dakar Thiès Mbour Total
Hospital 4 1 5
FP reference center 1 1
Health center 14 1 15
Health post 20 4 2 26
Adolescent Counseling Center 3 1 4
Private clinic 10 2 1 13
NGO clinic 2 2
Pharmacy/ Private pharmacy 30 4 2 36
EPS 1 3 1 1 5
CMS 2 2
Total 89 12 8 109
Source: provider survey, September 2011
At the 109 SDPs visited, 155 providers were interviewed. Midwives represented the majority of  the 
sampling (54%); the strong presence of  midwives in the sampling is explained by the fact that they are 
the first line providers in FP service delivery. Counter staff  in pharmacies made up 19% followed by 
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pharmacists (17%) and doctors (6%). The other categories had little representation in the sampling. 
Table 3: Distribution of  providers by professional category 
Type of  provider Dakar Thiès Mbour Total
Midwife 68 10 5 83
Pharmacist 21 3 2 26
Doctor 8 1 1 10
Counter staff 28 2 30
Other 4 2 6
Total 129 16 10 155
Source: provider survey, September 2011
Women made up a majority of  the provider sampling (71.6%). In Mbour, the number of  men was higher 
(40%) compared to Thiès and Dakar (27.9% and 25% respectively).
Table 4: Distribution of  providers by gender
Gender Dakar Thiès Mbour TotalN % N % N % N %
Male 36 27.9 4 25 4 40 44 28.4
Female 93 72.1 12 75 6 60 111 71.6
Total 129 100 16 100 10 100 155 100
Source: provider survey, September 2011
The average age of  providers was 43.5 years with a minimum age of  25 and a maximum of  70. The average 
months of  EC experience was 59.4 months, or almost 5 years, which corresponds to the introduction 
of  training activities for providers within the national FP program that began in 2005. However, Table 5 
indicates that certain providers have experience (22 years) previous to the initiative to introduce EC into 
the national health system, which dates to 10 years ago with the introduction of  Pregnon and Norlevo in 
the public and private sectors. These providers were most likely using traditional contraceptive pills and 
perhaps IUDs, which were methods previously used for FP. 
Table 5: Distribution of  providers by age and EC experience
Dakar Thiès Mbour Total
Provider age (years)
N 129 16 10 155
Average 44 43 44 44
Minimum 25 29 31 25
Maximum 70 59 56 70
Number of  months of  EC experience 
N 111 15 10 136
Average 58 45 102 59
Minimum 0 1 36 0
Maximum 264 120 150 264
Table 6 shows the quasi-effectiveness of  EC provision. Amongst the 155 providers who have provided 
EC in the past, 92% continue to do so. However, 11 out of  83 midwives who have provided EC in the 
past no longer do. 
Table 6: Percentage of  providers currently offering EC by professional category and region
Professional category Dakar Thiès Mbour Total N % N % N % N %
Midwife 58 85.3 9 90.0 5 100 72 86.7
Pharmacist 21 100 3 100 2 100 26 100
Doctor 8 100 1 100 1 100 10 100
Counter staff 27 96.4 2 100 29 96.7
Other 4 100 2 100 6 100
Total 118 91.5 15 93.8 10 100 143 92.3
Key Opinion Leaders (KOL): Who are they? 
The choice of  KOLs was motivated by the major role that they play in the influencing the ideas and 
opinions of  community and especially for their role in decision-making at the social, political, and 
economic levels. Indeed, KOLs play a key role in the definition of  policies and national strategies. They 
fix national priorities, especially the allotment of  resources. Their decisions matter so it is important to 
understand better their opinions and perceptions on major social interest topics such as family planning 
and emergency contraception.
The involvement of  KOLs in EC repositioning strategies is justified by the fact that they are potential key 
supporters or critics of  EC. KOL integration in programs remains a fundamental issue for EC advocacy. 
In the context of  this study, a wide range of  KOLs was targeted from policy makers/program managers, 
members of  professional associations/networks, members of  local NGOs, development partners, CBO 
representatives, distributors, and private practitioners.
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Table 7: List of  visited institutions 
INSTITUTIONS INSTITUTIONS
Public policy makers: 
• Ministry of  Health and Prevention (DRH)
• Ministry of  National Education
• Ministry of  Youth 
• National Assembly 
Local NGOs:
• ASBEF





• Marie Stopes International (MSI)
Practitioners:
• A private doctor
Professional associations:
• Order of  Senegalese doctors 
• Order of  Senegalese pharmacists 
• National Association of  Senegalese Midwives
CBOs:
• Siggil Jiggen network 
• Forum for African Women Educationalist 
• Movement for Youth Action 
• Synergie Banlieue
Networks:
• Islamic and Population networks (Religious)
• Health journalists and Population networks
Distributors:
• PRODIPHARM
• National Supply Pharmacy 
• ADEMAS
Police:




Besides the KOLs who are directly involved in the management of  routine reproductive health programs 
(especially leaders in the Ministry of  Health, Ministry of  National Education, development partners, and 
local NGO members), the majority of  KOLs do not possess accurate information on EC. They know it 
by the name of  “the morning after pill,” but they cannot name different EC brands available in the country, 
nor can they discuss its mechanism of  action or its side effects. This is the case with members of  
parliament, journalists, religious leaders, and certain members of  CBOs. Thus it is important to increase 
EC knowledge amongst these KOLs by giving them more specific product information. Furthermore, it 
is important to raise awareness about product safety. This could also push leaders to adhere to policies 
that promote EC.
The best-known EC products 
According to KOLs, the main EC products available are the following:
• Norlevo® (1.5 mg), which was made available by the DRH before 2006, but it is currently only 
available in private pharmacies;
• Pregnon®, which was introduced in the public system by the national FP program since May 
2006 thanks to a UNFPA donation. However, the available stock expired in September 2010 
due to lack of  promotion and distribution by public sector providers;
• DUET, which is the new product that will replace Pregnon®;
• Optinor, which is only available in ASBEF facilities;
• Conventional contraceptives pills (Loféménal, Microval, ovrette, etc.);
• IUDs.
EC legal status 
The vast majority of  KOLs believe that EC products are legal based on the fact they are available in the 
FP national program alongside other contraceptive products and are sold in private pharmacies. Speaking 
of  Norlevo®, a member of  a professional association stated: “It is a licensed product. […] As for other products 
found in private pharmacies, it received the visa from Pharmacy and Laboratory Administration” (a member of  a 
professional association). However, according to some KOLs, although EC products are licensed, the 
pharmaceutical regulation of  contraceptives in general and EC in particular should be reviewed. One 
member of  a professional association stated: “Norlevo® figures on the list of  Table A drugs and should be sold 
5 The Camp Pénal Women’s Prison was not visited for administrative procedural reasons.
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upon presentation of  a prescription, but in reality, it is given upon demand” (a member of  a distributors network). 
According to these KOLs, this situation should be fixed because now, because “according to regulations, only 
doctors and midwives are allowed to prescribe this method; however, in practice, it has been noted that nurses provide this 
product. […] It is important therefore to eliminate some of  these contradictions” (a distributor). 
Product usefulness 
All KOLs are unanimous on the usefulness of  the product and believe that the product should be 
popularized for several reasons:
• “So that everyone will have the information”;
• “It is an efficient product to prevent unwanted pregnancies as well as cases of  death and some social situations 
(e.g. infanticide, abandonment, clandestine abortions and their social consequences)”;
• “It is a useful product that has its place in the system to respond to unmeet needs”;
• “It can help young people better manage their futures”;
• “It is easy to use”;
• “For different reasons, there are women who do not use a regular method of  contraception”.
Some KOLs justify the usefulness of  the product based on the fact that “it can help fight girls’ high dropout 
rate from school and it can help certain organizations fight against sexual violence by taking better care of  victims of  abuse 
or sexual violence” (a member of  a professional organization). 
Although for the popularization of  this product, some KOLs reveal their fears and believe that its use 
should be supervised because “it should not be used as the one and only method” (a decision maker). 
Some reservations on the part of  KOLs are for personal reasons: “Personally, as a Muslim, mother, and 
educator, I think that its use should be limited. Sociocultural values cannot be violated in one fell swoop. With this method, 
we must be careful not to offend people. Because of  the sensitivity of  this subject, religious leaders should be involved. But in 
critical situations (e.g. rape and incest), it should be used to help young people, at least on a psychological level” (a decision 
maker).
Product efficacy and safety 
According to KOLs, EC is considered effective and safe if  it is properly taken at the right time as well as 
properly conserved. In principle, all providers understand EC insofar as they have been trained. KOLs 
justify product efficacy by high demand in private pharmacies and because few failures and complaints 
have been reported. Only one member of  a CBO mentioned a failure. As for the side effects, the KOLs 
do not exclude them, but they are minor. According to some KOLs, “This product is safe due to the fact that 
before its introduction, as for any drug, it received approval from the DPL” (member of  a professional association). 
The KOLs do not exclude the probability of  the existence of  counterfeit products in the context of  the 
market, especially in the informal sector, which is very porous because it lacks an efficient monitoring 
system. According to KOLs, “As with all drugs, EC products can be objects of  counterfeit” (a decision maker). 
No KOL reported having seen or heard of  the existence of  counterfeit products. These KOLs depend 
on monitoring results: “All contraceptive products were enrolled in the quality control program and no counterfeit 
product was reported” (a program manager).
EC in Policies/Norms and national guidelines
EC has been incorporated in the latest Policies/Norms and Protocol (PNP) documents under Family 
Planning/Reproductive Health reviewed in 2007-2008. It also appears prominently in the new version 
of  PNP that became available in 2012. It must be noted that a majority of  KOLs are in favor of  EC 
integration into the national guidelines as long as “EC is part of  a range of  contraceptive products available in 
the national FP program” (a program manager/decision maker). However, KOLs are not very aware of  
these national guidelines. 
Supply source/logistics system
Senegal’s EC products are supplied through two systems. In the public sector, supply follows the official 
system of  contraceptive products and is done with the DRH with support from development partners, 
mainly UNFPA, which has supported the DRH in the establishment of  these products (Pregnon®) 
since 2006. In the first stage, the DRH directly dispatches the products to the medical regions. Districts, 
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where activities are implemented operationally, get their supply from their medical regions. Since 2010, 
through an agreement signed between the DRH and the Central Medical Stores (CMS), the latter does 
DRH’s purchasing and ensures supply and distribution according to the division’s recommendations, 
including donated products. A rates system for contraceptive products including EC was validated by 
the Ministry of  Health, who fixed and published the official prices for contraceptive products at all levels 
of  the health system. The lack of  contraceptive consumer data through the Quarterly Stock Registers 
(RTS) is a weak link in the supply system, as real consumption is not known, which in turn limits the 
quality of  product orders. Since 2010, the system has witnessed product shortage due to the expiration 
of  Pregnon6® because of  a lack of  promotion on the part of  providers. Currently, a new product named 
DUET has replaced Pregnon® in the public system. DUET was commissioned by the CMS in the 
context of  the agreement, but the quantities available did not cover the country’s annual needs. Qualified 
personnel at all public facilities, except at health huts, ensure EC provisions. Generally, gynecologists and 
midwives provide the product.
In the private sector, EC is sold in private pharmacies under the brand name Norlevo®. In private clinics, 
doctors and midwives generally provide EC through a prescription that the client can then fill at a private 
pharmacy. Norlevo® is sold to customers at 3,275 FCFA. Five main wholesalers share this private market: 
PRODIPHARM, LABOREX, SODIPHARM, COPHASE, and BIOPHRAM. According to estimates, 
“almost 80,000 units of  Norlevo® are consumed in private pharmacies. […] The Dakar region represents almost 60% 
of  the national market. […] The product is especially used in cities” (a distributor). 
At ASBEF, “Optinor® is available thanks to support from the IPPF. It is sold at 2,000 FCFA” (an NGO employee).
EC research
Few KOLs were informed about the existence of  EC studies done in Senegal and their conclusions. The 
principal studies that were cited by KOLs were: 
• “EC: A Glance at the Issue in Senegal” (Population Council 2005);
• “Diagnostic Study on EC” (CEFOREP/2006);
• “Study on the Prevention of  Unwanted Pregnancies in Schools in the Pikine-Guédiawaye Region” (Population 
Council et CEFOREP 2007);
• “Study on EC in Private Pharmacies” (Population Council 2009).
Some KOLs expressed interest in certain research concerns:
• EC acceptability by the population and by decision makers;
• Stigmatization of  EC users;
• Religious aspects linked to EC use;
• Efficacy and safety of  the product;
• Perception of  parents and of  the community of  EC use by adolescents/unmarried youth;
• Effects of  repeated use/abuse;
• EC use and exposure to HIV/AIDS;
• KAP survey among youth;
• KAP survey among providers.
KOL EC Attitudes, Opinions, and Perceptions
Product acceptability
Overall, KOLs have a high opinion of  EC. They think that it has a place in the range of  contraceptives 
and may provide a remedy in certain circumstances (e.g. forgotten pill, rape, incest, etc.). According to 
some, “It should be promoted even amongst young single people because it prevents unwanted pregnancies (especially in 
the case of  neglecting to take the pill, rape, and incest) and their social consequences (e.g. induced abortion, infanticide)” 
(***author). 
This is confirmed by the comments of  some KOLs:
6 Almost 25,000 units of  Pregnon expired due to failure of  providers to deliver the product. This shortage reflects the dysfunctional supply and management system of  contraception products 
noted in 2011
9 www.popcouncil.org
“This is a method that we need in the context of  our activities because unwanted pregnancies can have very serious social 
consequences (for example, women imprisoned for infanticide)” (member of  a professional association). 
“For young people who are not married, I am not against it. The evidence shows that today sexual intercourse is trivialized 
even though we are in a Muslim country. It would be hypocritical to remain silent. […] I would prefer that they use EC 
than commit infanticide” (NGO member). 
EC can contribute to FP repositioning 
“We are in advocacy. We must help people correct certain errors. Thus, it must be known and accepted by the whole 
population, and not be limited to only one target (youth)” (program manager). 
However, some believe that distribution should be accompanied with advice for the following reasons: 
• Better targeting of  men since EC is a product destined specifically for women but is not known 
to men who might need to buy it for their partners. Indeed, one distributor stated that “70 to 
80% of  those who buy it are men. It is a product destined for women but bought by men. They are relatively 
young and they know the price” (distributor). 
• Inform EC users that this is an exceptional method that cannot replace regular contraception 
because “young people seem to use it as regular contraception” (program manager).  
• Inform young people that EC does not protect against STIs because “EC users are more prone to 
sexual libertinism and to not protecting themselves against STIs and HIV” (NGO member). 
The KOLs put forward some reservations about EC use, especially promiscuity, abuse, replacement of  
regular FP methods, religious considerations, and lack of  protection against STIs/HIV/AIDS.
According to one KOL: “It should be popularized, but we should first promote condoms to protect against STIs/HIV. 
It is a back up method that does not protect against AIDS” (members of  professional associations). 
Perceptions of provider attitudes toward the product and its acceptability
According to some KOLs, providers still feel some reluctance despite training. This would often be 
linked to personal issues. 
“There are some limitations with providers. Midwives are a bit blocked; they make the connection with abortion. Perhaps 
there is also a link with the target (young people)” (development partner). 
“With providers of  a certain age bracket, there could also be a problem because they envision their daughters in front of  
them. Their reactions sometimes go beyond the work setting” (NGO representative). 
“For providers, there are still some stereotypes. They have not yet fully accepted this method. […] They are concerned with 
overuse. And we find that counseling is now very biased towards injections and implants” (public authority). 
EC provision
The opinions of  KOLs remain divided as to who should receive EC:
For some: “EC must be limited to certain categories of  women: those with an at risk pregnancy, victims of  rape or sexual 
assault, prostitutes, and woman who have occasional sex (e.g. wives of  emigrants, adolescents)” (member of  a CBO).
For others: “EC must be available for all women who need it as long as there is no medical contraindication for the 
method” (decision maker).
It is the same in regards to where EC should be made available: some believe that EC services should be 
expanded to other types of  less conventional sanitary facilities such as sanitary facilities in military camps, 
Counseling Centers for Adolescents (CCA), Medical Infirmaries for Schools (IME), and universities. 
Others do not think that EC should be available at the community level: “There is no problem in health posts. 
As for the huts, I suggest waiting until the initial experience is firmly established and even health workers at this level may 
overuse it” (program manager).
Repeated EC use 
The vast majority of  KOLs believe that contraceptive use should be exceptional; they define repeated 
use as exceeding once a year. The vast majority of  KOLs argue that repeated use is a reality that is mostly 
seen in private pharmacies. According to pharmacists, repeated use is noted mainly with young people. 
However, the lack of  reliable statistics does not allow them to confirm this. 
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KOLs believe that repeated use can cause problems, especially:
• Abuse of  product;
• Replacement or halt of  regular contraception;
• Exposure to HIV.
Barriers to EC Provision and Access
EC Access
According to KOLs, the main barriers to EC access are the following: 
• Lack of  information;
• Provider’s attitude (e.g. reception or bias);
• Product unavailability;
• Shame;
• Distance from supply source, mainly the SDP;
• High cost of  EC products in pharmacies;
• Side effects linked to product use;
• Stigma especially in areas where social pressure is strong: “When someone asks for this product, you 
say to yourself  that he has done something or has the intention of  doing something” (decision maker);
• Religious convictions;
• Husband’s lack of  understanding;
• Rumors about contraception in general.
Barriers to EC Provision
According to KOLs, the main barriers to EC provision are the following: 
• Provider’s lack of  training;
• Religious convictions;
• Product unavailability due to the expiration of  the previous stock and the non-renewal of  the 
stock at SDP7;
• The wait time is considered too long by client;
• Administrative paperwork faced by clients;
• Unsuitable operating hours;
• Lack of  privacy and anonymity at visits (recording of  personal information such as name or 
address) at public facilities;
• Lack of  counseling at pharmacies where client-provider interaction is very low (no space for 
counseling).
According to KOLs, the main challenges to EC promotion are the following: 
• Access to product information and communication;
• Product availability:
• Provider training, including pharmacists and counter staff;
• Geographic and financial accessibility;
• Support from the public and certain providers;
• Harmonization of  practices on usage times because pharmacists rely on product inserts;
• Regulatory review (Table A drug); it would therefore be necessary to declassify this product to 
facilitate access;
• Quality of  service (e.g. good counseling, privacy, anonymity, and lack of  stigma).
7 The previous stock of  Pregnon acquired through the DRH expired in September 2010, and it was only renewed recently. The amount available does not cover the regions’ annual needs. 
The lack of  availability of  EC products is in a context of  overall contraceptive product shortage due to the problem of  retaining information, which occurs when the quarterly inventories 
required for planning future contraceptive needs are not transmitted
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KOL Recommendations for EC Promotion 
According to KOLs, EC promotion should be a multisectoral approach that involves a variety of  
stakeholders, namely:
Public authorities (Ministry of  Health, Ministry of  National Education, Ministry of  Justice, Ministry of  
the Family, Ministry of  Youth, etc.):







KOLs have made the following recommendations for priority EC intervention:
• Strengthen information for a wider dissemination of  the product;
• Train providers;
• Ensure proper logistical management to guarantee product availability;
• Increase financial accessibility;
• Develop partnerships through more involvement of  pharmacists;
• Develop advocacy with decision makers;
• Develop research on product acceptability and safety. 
EC Training for Providers 
Counseling is an important component of  service delivery that guarantees not only the client’s informed 
choice but also, as a result, the quality of  services offered. The graph below indicates that almost 
one third of  providers have not had any training in FP counseling. The training deficit is particularly 
noticeable with providers in pharmacies: only 13% of  counter staff  and 42% of  pharmacists have 
received training in FP counseling. The percentage is 94 amongst midwives. This is due to the fact that 
FP training programs have targeted public sector providers; the private sector benefited from few FP 
training programs. It is important to better target this sector in order to harmonize FP service delivery 
at a national level. 
Graph 1: Proportion of  providers previously trained in FP counseling by qualification
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Table 8 shows that EC training is not very integrated in the initial training for providers. Only 22.6% of  providers 
received EC training during their basic training. Indeed, EC integration in the provider-training curriculum 
is very recent. 51.6% of  them received it while on the job. It can be noted that 38.1% of  providers have 
never had any specific EC training, nearly four providers in ten. Dakar has the highest rate of  providers 
who have never received specific EC training (39.5%). 
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N % N % N % N %
Trained specifically in EC during basic training 26 20.2 4 25 5 50 35 22.6
Trained specifically in EC on the job 65 50.4 10 62.5 5 50 80 51.6
Has not received specific training in EC 51 39.5 3 18.8 2 20 56 36.1
Trained in EC during the last 12 months 18 14 6 37.5 1 10 25 16.1
Only 16.1% received specific EC training in the 12 months preceding the survey.
Table 9: Percentage of  providers with EC training by professional category
Professional Category Dakar Thiès Mbour TotalN % N % N % N %
Midwife 51 75 7 70 3 60 61 73.5
Pharmacist 12 57.1 3 100 2 100 17 65.4
Doctor 5 62.5 1 100 1 100 7 70
Counter staff 7 25 2 100 9 30
Other 3 75 2 100 5 83.3
Total 78 60.5 13 81.3 8 80 99 63.9
63.9% of  providers who have already provided EC received specific EC training. The highest percentages 
of  providers without EC training were found with counter staff  (70%) and pharmacists (34.6%).
EC Knowledge 
Table 10 shows that there is significant percentage of  providers who do not understand EC mechanism 
of  action: 57.4% quoted the stoppage of  ovulation and 63.9% the prevention of  egg implantation.
Table 10: Percentage of  providers’ understandings of  the EC mechanism of  action
Without Training With Training Total
N % N % N %
Inhibits ovulation 25 44.6 64 64.6 89 57.4
Impedes implantation 31 55.4 68 68.7 99 63.9
Induces abortion 1 1.8 1 1 2 1.3
Kills the spermatozoon 9 16.1 19 19.2 28 18.1
Do not know 10 17.9 7 7.1 17 11
Other 6 10.7 17 17.2 23 14.8
The period of  use of  EC is 120 hours 11 19.6 42 42.4 53 34.2
There are differences in what trained providers and untrained providers know about the EC mechanism 
of  action. 44.6% of  untrained providers indicated the blocking ovulation as the EC mechanism of  
action as opposed to 64.6% of  trained providers. Also, few providers are aware of  the newest guidelines 
related to the timing of  EC administration, which is now 120 hours. The highest percentages regarding 
this newest guideline were found with doctors and midwives (50% and 41% respectively). On the other 
hand, the level of  knowledge of  pharmacists remained low (11.5%). Differences between trained and 
untrained providers persist. 
Graph 2 also reveals that a large number of  providers do not know that pregnancy is an exclusion 
criterion for use. More than half  of  providers did not cite pregnancy as an EC exclusion criterion8.
































It can be noted that few providers cited cervix cancer as an EC exclusion criterion. 
The study results also reveal that knowledge around EC’s mechanism of  action remains low amongst 
providers. Few of  them could give correct answers as to the EC mechanism of  action, the time of  
use, and the eligibility criteria. It is important to build providers’ knowledge in this area through the 
organization of  training sessions. 
8 Training documents mention that the presence of  a pregnancy was a criterion of  non-eligibility for EC. Research has shown that EC use does not interfere with the progress of  a pregnancy.
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Opinions about EC 
It should be noted that few providers equate EC practice with a form of  abortion. 11% of  them believe 
that EC would be a form of  abortion. 
Table 11: Percentage of  providers who think EC is a form of  abortion
Professional category Dakar Thiès Mbour TotalN % N % N % N %
Midwife 4 5.9 4 4.8
Pharmacist 6 28.6 2 100 8 30.8
Counter staff 5 17.9 1 50 6 20
Total 15 11.6 15 9.7
However, amongst pharmacists, a significant number of  counter staff  (20%) and pharmacists (30.8%) 
equate it with abortion. Moreover, there is still much resistance in regards to the eligibility of  all women 
for EC use, which is contrary to national guidelines that state that all women are eligible for this method 
if  there are no medical contraindications.
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Indeed, the percentage of  providers who stated that all women regardless of  marital status were eligible 
for EC was 75.8% and 64.3% respectively for trained and untrained providers. Less than 45% of  
providers believe that married women and adolescents were eligible for EC. 
Although a majority of  providers believe that EC is a safe product, few of  them stated that it should be 
sold without a prescription (42.4% and 37.5% respectively for trained and untrained providers).
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In addition, they are not in favor of  providing EC to women in anticipation of  unprotected sex.
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Graph 5 indicates that a vast majority of  providers is in favor of  EC being provided by qualified medical 
personnel (e.g. doctors, midwives, and pharmacists). Most of  them are reluctant as to the provision by 
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others besides these types of  providers. Only 40.6% of  providers believe that social workers should 
provide EC. Indeed, the percentage of  providers in favor of  EC being provided by community workers 
(e.g. community health agents, and traditional birth attendants) remains very low (less than 20%).
Table 12: Distribution of  providers by opinions on where EC should be offered
These findings are similar regarding where EC should be 
offered. Opinions are mostly in favor of  conventional medical 
facilities (e.g hospitals, health post and centers, private clinics 
and pharmacies) as opposed to other non-conventional facilities 
such as health huts, school infirmaries, and police. The latter 
could enhance access to EC services for vulnerable groups such 
as students, rural women, and prisoners. A significant percentage 
of  providers (41.1%) are not in favor of  EC provision in 
Adolescent Counseling Centers, which are place specifically 
reserved for that target. 
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If  a majority of  providers are in favor of  EC being provided to victims of  rape and sexual abuse, and 
women who have unprotected sex and want access to EC, opinions are more mixed in regards to EC 
use by sex workers, married women, single adolescents, and women living in conflict zones (refugees). 
Perceptions of  EC 
Providers were interviewed about their perceptions of  the profile of  the average EC user. More than 
half  of  providers indicated that they believe EC users are less than 30 years old. Almost 35% indicated 
the age range would be between 20 and 29 years old, 15% between 15 and 19 years old, and 4% at less 
than 15 years old. On the other hand, 29% of  providers believe that women of  all ages would be EC 
users. However, a small percentage felt that they would be older than 40. 
Table 13: Distribution of  providers by opinions on age of  EC users 
Ages Dakar Thiès Mbour TotalN % N % N % N %
Less than 15 years 4 3.1 2 12.5 6 3.9
Between 15 and 19 years 20 15.5 4 25 24 15.5
Between 20 and 29 years 46 35.7 3 18.8 5 50 54 34.8
Between 30 and 39 years 16 12.4 16 10.3
40 years and older 3 2.3 3 1.9
Women of  all ages 34 26.4 6 37.5 5 50 45 29
Other 1 0.8 1 0.6
Do not know 5 3.9 1 6.3 6 3.9
Total 129 100 16 100 10 100 155 100
In addition, providers’ opinions on repeated use were discussed. The vast majority believes that EC use 
should be limited. Almost 76% believe that it should not exceed four times a year. This includes almost 
two providers in ten who state that EC should be used only once a year and almost six providers in ten 
believe that EC should be used between two and four times a year. Few providers believe that EC should 
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Table 14: Distribution of  providers by opinions on number of  times a woman can use EC per year 
There is a negative perception by providers towards 
women who use EC. Almost 70% of  them believe 
that they run a higher risk of  risky sexual behavior, 
will have an STI (68%), will have multiple sexual 
partners (58%) and will not use regular contraception 
(57%).
Table 15: Distribution of  providers by perceptions of  women who use EC 
Without training With training Total
N % N % N %
More likely to engage in risky sexual behaviors 41 73.2 67 67.7 108 69.7
More likely to have multiple sexual partners 31 55.4 59 59.6 90 58.1
More likely to have an STI 38 67.9 67 67.7 105 67.7
More likely to not be able to use other contraceptive methods 33 58.9 56 56.6 89 57.4
EC Service Delivery 
The data in Table 16 show that while the majority of  providers inform their clients of  the EC mechanism 
of  action (72%) and how it should be used (67%), and about FP (67%), few of  them refer clients to 
FP service (28%) or to other DRH services (29%). Almost half  (49.7%) inform clients of  side effects, 
almost one third (32.9%) of  providers do not give FP advice.
Table 16: Distribution of  providers by services normally provided to EC
Total
N %
Provides only EC pills 52 33.5
Provides general information about EC 92 59.4
Provides instructions on how to take EC 104 67.1
Provides the mode of  use of  EC 112 72.3
Provides information on the side effects 77 49.7
Provides advice on family planning 104 67.1
Provides information on STIs and HIV 83 53.5
Responds to questions and concerns 69 44.5
Refers to family planning services 43 27.7
Refers to other services 45 29
Offers other services to EC clients 11 7.1
A vast majority of  providers indicated that they normally offer Norlevo® to their clients (almost eight 
providers in ten). 











Norlevo Pregnon Lo-Femenal Securil Ovrette Microval IUD Stediril Adepal Optinor Neogynon
Besides Norlevo®, Pregnon® is still the most offered product. As the data in Graph 7 indicates, other EC 
products remain scarce in routine EC provision.
According to providers, EC products usually available in public facilities were mostly Lo-Femenal (79%), 
Ovrette (73%), and IUDs (54%). It can be deduced that EC products, specifically, are not readily available 
in public facilities. Pregnon® was only cited by 40% of  providers and Norlevo® by only 2% of  providers. 
It can be deduced that providers also use other options besides Pregnon. In private pharmacies, Norlevo® 
is cited (98%). However, other products such as Securil and Microval are available. We note the presence 
of  a larger variety of  EC products in private clinics as the data in Graph 7 shows. This indicates that 
there are several options in EC provision. Other products are rare
Total
N %
Once a year 15 20.3
2-4 times a year 41 55.4
5-10 times a year 1 1.4
Once a month 6 8.1
As often as necessary 9 12.2
Other 1 1.4
Do not know 1 1.4
Total 74 100
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Conclusion 
The KOL and provider survey results reveal that EC is an integral part of  the national FP program. In 
fact, EC ranks high not only in policy documents, norms, and protocols regarding DRH/FP service 
delivery, but also in provider training documents. KOLs and providers are conscious of  the importance of  
EC in the prevention of  unwanted pregnancies and are in favor of  EC integration in national guidelines. 
However, it is evident from these results that there is an urgent need to improve EC accessibility and 
the quality of  its services. The vast majority of  KOLs and providers believe that community awareness 
and the popularization of  the product should be the primary activities to build awareness amongst the 
populations, young people in particular, about the product. The information given to communities could 
also contribute to reduce stigma, biases, worries, and reluctance about EC use.  
The persistence of  these prejudices toward EC could be linked to EC’s recent past in Senegal. 
Its official introduction to the national system goes back less than six years. The ideas and experiences are 
being built now, and it takes time to change ideas and behavior. EC history in Senegal is highly dependent 
on FP history, which is characterized by low use of  modern methods and by the weight of  sociocultural 
pressures. However, the perspective of  better acceptance of  the product is open. In fact, facing the 
scope of  sexual violence/abuse, induced abortions, and the question of  women’s and adolescent health 
rights, there are more and more decision makers and communities who wish to preserve the health 
and well being of  certain vulnerable groups, particularly adolescents/young people and women. These 
factors could provide the momentum needed for EC promotion.
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Recommendations 
The primary recommendations of  the study are: 
• Community awareness for wider product knowledge;
• Provider training;
• Establishment of  a logistics management system to ensure product availability;
• Improve product affordability;
• Development of  partnerships, especially through greater involvement of  pharmacists;
• Development of  advocacy activities with decision makers.
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